Phase Ii Dose-Response Clinical Trial Using Febuxostat (Tmx-67), A Novel-Type Xanthine Oxidase/Xanthine Dehydrogenase Inhibitor, For Gout And Hyperuricemia.
ARTHRITIS AND RHEUMATISM(2003)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined